Showing results (41-50 of 106) with videos related to
Sort By:
Pageof 11
Antiviral Therapy|June 26, 2014
Switching safely: pharmacokinetics, efficacy and safety of switching efavirenz to maraviroc twice daily in patients on suppressive antiretroviral therapyLaura Waters, Akil Jackson, Laura Else, et al.Clinical Medicine (London, England)|November 17, 2020
<i>Pneumocystis</i> pneumonia, a COVID-19 mimic, reminds us of the importance of HIV testing in COVID-19Sophie Kelly, Laura Waters, Muge Cevik, et al.International Journal of Radiation Oncology, Biology, Physics|November 13, 2018
A Nomogram for Testosterone Recovery After Combined Androgen Deprivation and Radiation Therapy for Prostate CancerDaphna Y Spiegel, Julian C Hong, Taofik Oyekunle, et al.AIDS (London, England)|November 25, 2010
A phase IV, double-blind, multicentre, randomized, placebo-controlled, pilot study to assess the feasibility of switching individuals receiving efavirenz with continuing central nervous system adverse events to etravirineLaura Waters, Martin Fisher, Alan Winston, et al.Journal of Pharmaceutical Analysis|March 4, 2020
Thermodynamics of clay-drug complex dispersions: Isothermal titration calorimetry and high-performance liquid chromatographyAna-Maria Totea, Juan Sabin, Irina Dorin, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|July 22, 2009
Pharmacokinetics and safety of etravirine administered once or twice daily after 2 weeks treatment with efavirenz in healthy volunteersMarta Boffito, Akil Jackson, Mohammed Lamorde, et al.HIV Medicine|December 6, 2021
Bone mineral density, kidney function and participant-reported outcome measures in women who switch from tenofovir disoproxil emtricitabine and a nonnucleoside reverse transcriptase inhibitor to abacavir, lamivudine and dolutegravirLucy Campbell, Fowzia Ibrahim, Birgit Barbini, et al.AIDS Research and Human Retroviruses|September 12, 2019
Perspectives on the Barrier to Resistance for Dolutegravir + Lamivudine, a Two-Drug Antiretroviral Therapy for HIV-1 InfectionMarta Boffito, Laura Waters, Pedro Cahn, et al.Advances in Radiation Oncology|July 6, 2023
Toxicity and Outcomes of Moderately Hypofractionated Radiation for Prostate Cancer With Seminal Vesicle InvolvementScarlett Acklin-Wehnert, David Carpenter, Divya Natesan, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 7, 2021
Human Immunodeficiency Virus (HIV) Care Models During the Coronavirus Disease 2019 (COVID-19) EraGiovanni Guaraldi, Jovana Milic, Esteban Martinez, et al.Pageof 11